
Anne Marie Sabrina Wehbe
Examiner (ID: 18312)
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1632, 1633, 1634 |
| Total Applications | 1342 |
| Issued Applications | 603 |
| Pending Applications | 239 |
| Abandoned Applications | 542 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18545491
[patent_doc_number] => 11718832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Method to reduce oncogenic potential of induced pluripotent stem cells from aged donors
[patent_app_type] => utility
[patent_app_number] => 15/517014
[patent_app_country] => US
[patent_app_date] => 2015-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 23935
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517014
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/517014 | Method to reduce oncogenic potential of induced pluripotent stem cells from aged donors | Oct 5, 2015 | Issued |
Array
(
[id] => 10679561
[patent_doc_number] => 20160025706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY'
[patent_app_type] => utility
[patent_app_number] => 14/875725
[patent_app_country] => US
[patent_app_date] => 2015-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4546
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14875725
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/875725 | METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY | Oct 5, 2015 | Abandoned |
Array
(
[id] => 11656076
[patent_doc_number] => 09669058
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-06
[patent_title] => 'Engineering and delivery of therapeutic compositions of freshly isolated cells'
[patent_app_type] => utility
[patent_app_number] => 14/834932
[patent_app_country] => US
[patent_app_date] => 2015-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 15121
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14834932
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/834932 | Engineering and delivery of therapeutic compositions of freshly isolated cells | Aug 24, 2015 | Issued |
Array
(
[id] => 12057181
[patent_doc_number] => 20170333524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'MOLECULAR CONSTRUCTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/327984
[patent_app_country] => US
[patent_app_date] => 2015-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13827
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15327984
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/327984 | Molecular constructs and uses thereof | Jul 21, 2015 | Issued |
Array
(
[id] => 11668468
[patent_doc_number] => 20170157188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 15/325562
[patent_app_country] => US
[patent_app_date] => 2015-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18701
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325562
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/325562 | Oncolytic virus for expression of immune checkpoint modulators | Jul 15, 2015 | Issued |
Array
(
[id] => 10466356
[patent_doc_number] => 20150351371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'Hybrid Light Chain Mice'
[patent_app_type] => utility
[patent_app_number] => 14/800257
[patent_app_country] => US
[patent_app_date] => 2015-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 26462
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14800257
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/800257 | Hybrid light chain mice | Jul 14, 2015 | Issued |
Array
(
[id] => 10421135
[patent_doc_number] => 20150306147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'ISOLATED LIVER STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/795195
[patent_app_country] => US
[patent_app_date] => 2015-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 28540
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14795195
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/795195 | Isolated liver stem cells | Jul 8, 2015 | Issued |
Array
(
[id] => 10421135
[patent_doc_number] => 20150306147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'ISOLATED LIVER STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/795195
[patent_app_country] => US
[patent_app_date] => 2015-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 28540
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14795195
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/795195 | Isolated liver stem cells | Jul 8, 2015 | Issued |
Array
(
[id] => 10411746
[patent_doc_number] => 20150296755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'TRANSGENIC ANIMALS CAPABLE OF BEING INDUCED TO DELETE SENESCENT CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/792208
[patent_app_country] => US
[patent_app_date] => 2015-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 8272
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14792208
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/792208 | Transgenic animals capable of being induced to delete senescent cells | Jul 5, 2015 | Issued |
Array
(
[id] => 10387990
[patent_doc_number] => 20150272997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'Mesenchymal Stem Cells and Uses Therefor'
[patent_app_type] => utility
[patent_app_number] => 14/739924
[patent_app_country] => US
[patent_app_date] => 2015-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9886
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14739924
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/739924 | Mesenchymal Stem Cells and Uses Therefor | Jun 14, 2015 | Abandoned |
Array
(
[id] => 11568854
[patent_doc_number] => 20170107498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'NOVEL AND EFFICIENT METHOD FOR REPROGRAMMING IMMORTALIZED LYMPHOBLASTOID CELL LINES TO INDUCED PLURIPOTENT STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/316098
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13288
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316098
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/316098 | NOVEL AND EFFICIENT METHOD FOR REPROGRAMMING IMMORTALIZED LYMPHOBLASTOID CELL LINES TO INDUCED PLURIPOTENT STEM CELLS | Jun 4, 2015 | Abandoned |
Array
(
[id] => 10361971
[patent_doc_number] => 20150246976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'Hybrid Light Chain Mice'
[patent_app_type] => utility
[patent_app_number] => 14/715145
[patent_app_country] => US
[patent_app_date] => 2015-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 26436
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14715145
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/715145 | Hybrid light chain mice | May 17, 2015 | Issued |
Array
(
[id] => 10361973
[patent_doc_number] => 20150246977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'Hybrid Light Chain Mice'
[patent_app_type] => utility
[patent_app_number] => 14/715147
[patent_app_country] => US
[patent_app_date] => 2015-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 26434
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14715147
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/715147 | Hybrid light chain mice | May 17, 2015 | Issued |
Array
(
[id] => 10347807
[patent_doc_number] => 20150232812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'HERPES VIRUS STRAINS'
[patent_app_type] => utility
[patent_app_number] => 14/700036
[patent_app_country] => US
[patent_app_date] => 2015-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5713
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14700036
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/700036 | HERPES VIRUS STRAINS | Apr 28, 2015 | Abandoned |
Array
(
[id] => 11604386
[patent_doc_number] => 20170121687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'METHODS OF CELLULAR REPROGRAMMING'
[patent_app_type] => utility
[patent_app_number] => 15/306045
[patent_app_country] => US
[patent_app_date] => 2015-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 11926
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15306045
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/306045 | METHODS OF CELLULAR REPROGRAMMING | Apr 22, 2015 | Abandoned |
Array
(
[id] => 11436347
[patent_doc_number] => 20170037369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/305337
[patent_app_country] => US
[patent_app_date] => 2015-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 50078
[patent_no_of_claims] => 116
[patent_no_of_ind_claims] => 57
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15305337
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/305337 | Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy | Apr 22, 2015 | Issued |
Array
(
[id] => 11441964
[patent_doc_number] => 20170042985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'METHODS OF USING CYCLOOXYGENASE-PROSTACYCLIN SYNTHASE FUSION GENE'
[patent_app_type] => utility
[patent_app_number] => 15/305719
[patent_app_country] => US
[patent_app_date] => 2015-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10479
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15305719
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/305719 | METHODS OF USING CYCLOOXYGENASE-PROSTACYCLIN SYNTHASE FUSION GENE | Apr 21, 2015 | Abandoned |
Array
(
[id] => 10397453
[patent_doc_number] => 20150282460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'ANIMAL MODEL WITH HUMAN IMMUNE SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 14/679951
[patent_app_country] => US
[patent_app_date] => 2015-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11151
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14679951
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/679951 | ANIMAL MODEL WITH HUMAN IMMUNE SYSTEM | Apr 5, 2015 | Abandoned |
Array
(
[id] => 10428182
[patent_doc_number] => 20150313193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-05
[patent_title] => 'Common Light Chain Mouse'
[patent_app_type] => utility
[patent_app_number] => 14/679949
[patent_app_country] => US
[patent_app_date] => 2015-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27531
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14679949
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/679949 | Common Light Chain Mouse | Apr 5, 2015 | Abandoned |
Array
(
[id] => 10372367
[patent_doc_number] => 20150257373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY'
[patent_app_type] => utility
[patent_app_number] => 14/676312
[patent_app_country] => US
[patent_app_date] => 2015-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7348
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14676312
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/676312 | MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY | Mar 31, 2015 | Abandoned |